A recent study indicates that patients who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who end traditional lifestyle plans.
Published data in a major health publication demonstrates that while overweight people frequently drop a large proportion of their total mass while on the medication, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing such medications need to be cognizant of the risk of rapid weight regain when the treatment ends," stated researcher Dr. Susan Jebb.
Such speed of recovery suggests a reversion to pre-treatment mass within about 18 months.
Comparing Therapies
The analysis, which examined dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with conventional dieting.
Researchers point out that individuals who lose weight through dieting generally have a slower creep back—around 100 grams monthly—once they finish.
Explaining the Quick Rebound
Nutrition scientists propose the way of the drugs is key to understanding the amplified regain.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement leads to appetite is unsuppressed, making excessive eating far more likely."
A Chronic Issue?
The NHS suggest the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts say that, given the high risk of relapse, the therapy is often life-long.
This view is echoed by pharmaceutical companies, who state that the results "highlight the long-term nature of obesity," similar to managing diseases like high blood pressure.
User Experiences
Individuals who have come off the medication describe a intense return of hunger.
"I experienced something that goes on and I was suddenly starving," described a patient.
This difficulty is exacerbated if individuals have not adopted permanent lifestyle or habit changes during therapy.
Growing Interest
Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
- Adoption is higher among females than males.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while these medications are powerful agents for weight loss, they are not a standalone fix and long-term success hinges on ongoing behavioural management.
